Ioanna Κechribari

Mrs. Ioanna Κechribari

Harokopio University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
EPEmilia Papakonstantinou
Emilia Papakonstantinou
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
ΚSΚyriaki Sotirakoglou
Κyriaki Sotirakoglou
Petros A. TarantilisPetros A. Tarantilis
Petros A. Tarantilis
TGTheodora Gourdomichali
Theodora Gourdomichali
Antonis ZampelasAntonis Zampelas
Antonis Zampelas
It has been suggested that coffee may affect the gut-brain axis with conflicting outcomes. Moreover, there is insufficient evidence to determine whether the type or temperature of coffee consumed will have a different impact on the gut-brain axis. The purpose of this study was to investigate the effects of acute coffee consumption on the following: 1. self-reported GI symptoms and salivary gastrin, 2. stress indices [salivary cortisol and alpha-amylase (sAA)] and psychometric measures, and 3. blood pressure (BP), in healthy, daily coffee consuming individuals in non-stressful conditions. This was a randomized, double blind, crossover clinical trial, in which 40 healthy individuals (20 men, 20 women), 20–55 years of age, randomly consumed four 200 ml coffee beverages containing 160 mg caffeine (hot and cold instant coffee, cold espresso, hot filtered coffee), 1 week apart. Salivary samples and psychometric questionnaires were collected at baseline and post-coffee consumption at 15,30, and 60 min for salivary gastrin and sAA measurements and at 60,120, and 180 min for cortisol measurements. BP was measured at beginning and end of each intervention. ClinicalTrials.gov ID: NCT02253628 Coffee consumption significantly increased sAA activity (P = 0.041), with significant differences only between cold instant and filter coffee at 15 and 30 min post-consumption (P < 0.05). Coffee temporarily increased salivary gastrin, without differences between coffee types. Coffee did not affect salivary cortisol or self-reported anxiety levels. Coffee consumption significantly increased BP, within the healthy physiological levels, in a gender specific manner at the end of the experimental periods, without differences between coffee types. Acute coffee consumption in non-stressful conditions activated sAA and BP but not salivary cortisol, indicating activation of the sympathetic nervous system. Post-coffee sAA increase without a concomitant cortisol increase may also indicate that coffee may have some anti-stress properties.

28 May 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Michael GeorgoulisMichael Georgoulis
Michael Georgoulis
NYNikos Yiannakouris
Nikos Yiannakouris
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
KLKallirroi Lamprou
Kallirroi Lamprou
EPEleni Perraki
Eleni Perraki
Meropi KontogianniMeropi Kontogianni
Meropi Kontogianni
Although continuous positive airway pressure (CPAP) is the first-line treatment for obstructive sleep apnea (OSA), its cardiometabolic benefits are questionable. Our aim was to explore whether the combination of a weight-loss Mediterranean diet/lifestyle intervention with OSA standard care leads to greater cardiometabolic improvements compared with standard care alone. We randomly assigned 187 adult, overweight, polysomnography-diagnosed moderate-to-severe OSA patients to a standard care group (SCG, n = 65), a Mediterranean diet group (MDG, n = 62) or a Mediterranean lifestyle group (MLG, n = 60). All three groups were prescribed with CPAP. Additionally, the SCG only received brief written healthy lifestyle advice, while intervention arms were subjected to a six-month weight-loss behavioral intervention based on the Mediterranean diet. The MLG also received guidance for improving physical activity and sleep habits. Glucose metabolism indices, blood lipids, liver enzymes and blood pressure improved only in intervention arms, and were significantly lower compared to the SCG post-intervention (all p < 0.05). The age-, sex-, baseline- and CPAP use-adjusted relative risk (95% confidence interval) of metabolic syndrome was 0.58 (0.34–0.99) for the MDG and 0.30 (0.17–0.52) for the MLG compared to the SCG. The MLG additionally presented a lower relative risk of metabolic syndrome compared to the MDG (0.52 (0.30–0.89)). After further adjustment for body-weight change, a lower relative risk of metabolic syndrome was still evident for the MLG compared to the SCG. In conclusion, although standard care alone does not improve OSA patients’ cardiometabolic profile, its combination with a weight-loss Mediterranean diet/lifestyle intervention leads to significant cardiometabolic benefits.

4 April 2021 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
MKMeropi D Kontogianni
Meropi D Kontogianni
Michael GeorgoulisMichael Georgoulis
Michael Georgoulis
KLKallirroi Lamprou
Kallirroi Lamprou
ECElena Critselis
Elena Critselis
NYNikos Yiannakouris
Nikos Yiannakouris

18 February 2023 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
Michael GeorgoulisMichael Georgoulis
Michael Georgoulis
NYNikos Yiannakouris
Nikos Yiannakouris
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
KLKallirroi Lamprou
Kallirroi Lamprou
EPEleni Perraki
Eleni Perraki
Meropi KontogianniMeropi Kontogianni
Meropi Kontogianni

7 July 2021 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
MKMeropi D. Kontogianni
Meropi D. Kontogianni
Michael GeorgoulisMichael Georgoulis
Michael Georgoulis
KLKallirroi Lamprou
Kallirroi Lamprou
EVEmmanouil Vagiakis
Emmanouil Vagiakis
NYNikos Yiannakouris
Nikos Yiannakouris

28 June 2023 in Nutrition Research
Verified
Journal Article
Closed access
Ioanna ΚechribariIoanna Κechribari
Ioanna Κechribari
MKMeropi D. Kontogianni
Meropi D. Kontogianni
EFElizabeth Fragopoulou
Elizabeth Fragopoulou
RTRoxane Tenta
Roxane Tenta
Michael GeorgoulisMichael Georgoulis
Michael Georgoulis
NYNikos Yiannakouris
Nikos Yiannakouris